ERBB2 deficiency alters an E2F-1-dependent adaptive stress response and leads to cardiac dysfunction.
about
Costs, benefits and redundant mechanisms of adaption to chronic low-dose stress in yeastThe ErbB2ΔEx16 splice variant is a major oncogenic driver in breast cancer that promotes a pro-metastatic tumor microenvironment.The antineoplastic drug, trastuzumab, dysregulates metabolism in iPSC-derived cardiomyocytes.Acquired Resistance to Clinical Cancer Therapy: A Twist in Physiological Signaling.Molecular profiling of dilated cardiomyopathy that progresses to heart failure.
P2860
ERBB2 deficiency alters an E2F-1-dependent adaptive stress response and leads to cardiac dysfunction.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
ERBB2 deficiency alters an E2F ...... leads to cardiac dysfunction.
@en
type
label
ERBB2 deficiency alters an E2F ...... leads to cardiac dysfunction.
@en
prefLabel
ERBB2 deficiency alters an E2F ...... leads to cardiac dysfunction.
@en
P2093
P2860
P356
P1476
ERBB2 deficiency alters an E2F ...... d leads to cardiac dysfunction
@en
P2093
Catherine R Dufour
David W K Tsang
Geneviève Deblois
Lillian J Eichner
Marie-Claude Perry
William J Muller
P2860
P304
P356
10.1128/MCB.00895-14
P407
P577
2014-09-22T00:00:00Z